Article
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes.
Leukemia research - 1 Jan 2015
Zhang Ling, Padron Eric, Lancet Jeffrey
Abstract excerpt
Myelodysplastic syndromes (MDS) are a heterogeneous cluster of clonal hematopoietic neoplasms manifested by peripheral cytopenias, lineage dysplasia, and a predisposition to acute myeloid leukemia. The pathophysiology of MDS has not been well illustrated. Nevertheless, studies have implicated the MDS phenotype in a broad spectrum of genetic abnormalities. In addition to the known numerical and structural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
